Medicine & Health News

TAU researchers identify key role of NMDA receptors in brain function

Researchers at Tel Aviv University (TAU) have determined that the NMDA receptor (NMDAR) in the brain, long studied primarily for its role in learning and memory, also plays a crucial role in stabilizing brain activity. By setting the “baseline” level for activity in neural networks, the NMDAR helps maintain stable brain function amidst continuous environmental… Read More

TAU researchers suggest new target for Parkinson’s disease treatments

Researchers at Tel Aviv University (TAU) have found that a variant of the TMEM16F protein, caused by a genetic mutation, enhances the spread of Parkinson’s pathology through nerve cells in the brain. The researchers say that their discovery of a new factor in the pathology of Parkinson’s disease may serve as a target for developing… Read More

PTSD-related brain damage responds to a special protocol of hyperbaric therapy

Researchers at Tel Aviv University (TAU) and the Sagol Center for Hyperbaric Medicine and Research at the Shamir Medical Center have demonstrated that hyperbaric oxygen therapy (HBOT) improves the condition of PTSD sufferers who have not responded to psychotherapy or psychiatric medications. The researchers say that their unique therapeutic protocol affects the biological brain “wound”… Read More

Changes in the chromosomes of cancer cells may increase their sensitivity to anti-cancer drugs

Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University (TAU), in collaboration with the European Institute of Oncology in Milan, have extensively examined the characteristics of aneuploid cells, which have an abnormal number of chromosomes, and raised findings that may advance new cancer treatments. According to the researchers, “A… Read More

New TAU technology may enable early diagnosis of Parkinson’s disease

Researchers at Tel Aviv University (TAU) in cooperation with three major Israeli medical centers have developed a new method for detecting protein aggregation in cells, a hallmark of Parkinson’s disease. The technology can enable diagnosis up to 20 years before the first motor symptoms appear, facilitating treatment or even prevention of the severe disease, which… Read More

Closed-eye imaging can track pain in unresponsive patients

A new technological development from Tel Aviv University (TAU) can monitor changes in pupil size and gaze direction behind closed eyes using touchless infrared imaging. Tracking changes in pupil size can help identify a state of wakefulness in sleep, anesthesia, and intensive care and help track the depth of sedation, detect seizures and nightmares, and… Read More